Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026

📅 25/08/2026 11:00 📰 financialcontent 👁️ 0 lectures 🌍 États-Unis 📂 Science